Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
921.93
819.37
665.90
559.56
450.06
508.04
599.98
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
921.93
819.37
665.90
559.56
450.06
508.04
599.98
Raw Material Cost
585.46
528.35
406.10
340.62
245.60
235.54
262.84
Purchase of Finished goods
2.61
0.00
0.00
0.00
0.00
0.17
0.30
(Increase) / Decrease In Stocks
-43.85
-43.89
-21.48
-27.06
-17.09
7.58
26.56
Employee Cost
86.36
69.64
65.35
63.28
67.11
84.75
82.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
-0.01
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
174.17
154.59
132.31
133.11
104.67
205.49
246.21
Total Expenditure (Excl Depreciation)
804.75
708.69
582.28
509.95
400.28
533.52
618.19
Operating Profit (PBDIT) excl Other Income
117.18
110.68
83.62
49.61
49.78
-25.48
-18.21
Other Income
27.47
30.86
19.43
9.00
15.23
24.49
16.93
Operating Profit (PBDIT)
144.65
141.54
103.05
58.61
65.01
-0.99
-1.28
Interest
14.54
16.35
32.23
32.01
51.34
4.16
0.30
Exceptional Items
0.00
0.00
-6.78
0.00
0.00
0.00
200.93
Gross Profit (PBDT)
130.11
125.19
110.03
26.60
13.67
-5.15
199.35
Depreciation
34.55
33.24
54.79
87.02
108.92
125.92
129.94
Profit Before Tax
95.56
91.95
55.25
-60.42
-95.25
-131.07
69.41
Tax
-0.19
-3.12
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
95.76
95.06
55.25
-60.42
-95.25
-131.07
69.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
-6.78
58.47
-21.28
0.00
0.00
Net Profit
95.76
95.06
48.47
-1.95
-116.53
-131.07
69.41
Share in Profit of Associates
3.90
-2.90
-2.15
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
99.66
92.17
46.32
-1.95
-116.53
-131.07
69.41
Equity Capital
50.72
50.72
40.82
40.82
40.82
40.82
88.96
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,216.57
1,118.75
647.83
0.00
612.09
983.54
0.00
Earnings per share (EPS)
19.65
18.17
11.35
-0.48
-28.55
-32.11
7.8
Diluted Earnings per share
19.65
19.06
11.35
-0.48
-28.55
-32.11
7.8
Operating Profit Margin (Excl OI)
12.71%
13.51%
12.56%
8.87%
11.06%
-5.02%
-3.04%
Gross Profit Margin
14.11%
15.28%
16.52%
4.75%
3.04%
-1.01%
33.23%
PAT Margin
10.39%
11.6%
8.3%
-10.8%
-21.16%
-25.8%
11.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 12.52% vs 23.05% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 8.13% vs 98.99% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 5.87% vs 32.36% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -11.07% vs -49.27% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Orchid Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
921.93
0
921.93
Other Operating Income
0.00
0.00
0.00
Total Operating income
921.93
0
921.93
Raw Material Cost
585.46
0
585.46
Purchase of Finished goods
2.61
0
2.61
(Increase) / Decrease In Stocks
-43.85
0
-43.85
Employee Cost
86.36
0
86.36
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
174.17
0.00
174.17
Total Expenditure (Excl Depreciation)
804.75
0
804.75
Operating Profit (PBDIT) excl Other Income
117.18
0.00
117.18
Other Income
27.47
0
27.47
Operating Profit (PBDIT)
144.65
0
144.65
Interest
14.54
0
14.54
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
130.11
0
130.11
Depreciation
34.55
0
34.55
Profit Before Tax
95.56
0
95.56
Tax
-0.19
0
-0.19
Provisions and contingencies
0.00
0
0.00
Profit After Tax
95.76
0
95.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
95.76
0
95.76
Share in Profit of Associates
3.90
0
3.90
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
99.66
0
99.66
Equity Capital
50.72
0
50.72
Face Value
10.00
0
0.00
Reserves
1,216.57
0
1,216.57
Earnings per share (EPS)
19.65
0
19.65
Diluted Earnings per share
19.65
0
19.65
Operating Profit Margin (Excl OI)
12.71%
0%
0.00
12.71%
Gross Profit Margin
14.11%
0%
0.00
14.11%
PAT Margin
10.39%
0%
0.00
10.39%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 921.93 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 12.52% vs 23.05% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 99.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.13% vs 98.99% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 117.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5.87% vs 32.36% in Mar 2024
Annual - Interest
Interest 14.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -11.07% vs -49.27% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.71%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
